Mocetinostat April 12, 2017 Mocetinostat Trade Name Orphan Indication Myelodysplastic syndrome USA Market Approval USA USA Designation Date 2014-06-12 00:00:00 Sponsor Mirati Therapeutics, Inc.;9363 Towne Centre Drive, Suite 200;San Diego, California, 92121
